Cholesterol-Lowering Injectables: More Harm Than Good, States Journal of American Physicians and Surgeons
December 14, 2015 08:49 ET
|
Association of American Physicians and Surgeons
TUCSON, Ariz., Dec. 14, 2015 (GLOBE NEWSWIRE) -- Newly approved cholesterol lowering agents, Repatha (evolocumab) and Praluent (alirocumab), are being heavily promoted as a new breakthrough in...
Statin Overuse Risky, Warns Association of American Physicians and Surgeons (AAPS)
July 20, 2015 10:21 ET
|
Association of American Physicians and Surgeons
TUCSON, Ariz., July 20, 2015 (GLOBE NEWSWIRE) -- Two studies published in the July 14 issue of JAMA support new guidelines that could nearly double the number of Americans taking statin drugs to...